Matrix-metalloproteinases in bronchopulmonary carcinomas

• Martinella Catusse, C. ^[1] ; Nawrocki, B. ^[1] ; Gilles, C. ^[2] ; Birembaut, P. ^[1] ; Polette, M. ^[1]
  1. [1] I.N.S.E.R.M. U. 514 and Laboratoire Pol Bouin-C.H.U. de Reims, France
  2. [2] Laboratory of Biology of Tumours and Oevelopment-C.H.U. Sart-Tilman-Liege, Belgique
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 14, Nº. 3, 1999, págs. 839-843
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Matrix metalloproteinases (MMPs) represent a group of enzymes involved in the degradation of most of the components of the extrace llular matrix and therefore participate in tumoural invasion. MMPs, especially gelatinases A and B, MT1-MMP, the activator of gelatinase A, and stromelysin-3 were found overexpressed in many cancers including bronchopulmonary carcinomas. In vivo observations revealed that fibroblasts are the principal source of production of MMPs. Some of these enzymes such as MT1-MMP and stromelysin 3, displayed a focal stromal localisation near preinvasive and invasive tumour clusters. Futhermore, some tumour cell lines were shown to stimulate the expression of MT1-MMP by fibroblasts. All these in vivo and in vitro results suggest that certain tumour cells produce diffusible factors which could influence the MMP stromal expression. Among these factors, the TCSF (Tumor Collagenase Stimulatory Factor) which is known to upregulate some MMPs in vitro could be a good candidate for this stromal regulation, since it is produced by bronchial tumour cells in vivo. In this review, we address such a cooperation between tumour and stromal cells for the production of MMPs and emphasize their necessity for tumoural progression in bronchopulmonary carcinomas.